Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Revenue: 2018-2022

Historic Revenue for ADC Therapeutics (ADCT) over the last 5 years, with Dec 2022 value amounting to $209,908.

  • ADC Therapeutics' Revenue fell 81.01% to $14.5 million in Q3 2023 from the same period last year, while for Sep 2023 it was $52.8 million, marking a year-over-year decrease of 62.29%. This contributed to the annual value of $209,908 for FY2022, which is 518.89% up from last year.
  • Latest data reveals that ADC Therapeutics reported Revenue of $209,908 as of FY2022, which was up 518.89% from $33,917 recorded in FY2021.
  • Over the past 5 years, ADC Therapeutics' Revenue peaked at $118.3 billion during FY2018, and registered a low of $814 during FY2020.
  • Its 3-year average for Revenue is $81,546, with a median of $33,917 in 2021.
  • Per our database at Business Quant, ADC Therapeutics' Revenue slumped by 100.00% in 2019 and then skyrocketed by 4,066.71% in 2021.
  • Over the past 5 years, ADC Therapeutics' Revenue (Yearly) stood at $118.3 billion in 2018, then tumbled by 100.00% to $2,340 in 2019, then slumped by 65.21% to $814 in 2020, then skyrocketed by 4,066.71% to $33,917 in 2021, then spiked by 518.89% to $209,908 in 2022.